{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:10:19Z","timestamp":1793157019255,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00247-018-4154-4","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T05:00:27Z","timestamp":1526965227000},"page":"1472-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?"],"prefix":"10.1007","volume":"48","author":[{"given":"Ezekiel","family":"Maloney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Luana","family":"Stanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh S.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph K.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Steuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda I.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W. W.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"4154_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00247-017-3806-0","volume":"47","author":"EM Gale","year":"2017","unstructured":"Gale EM, Caravan P, Rao AG et al (2017) Gadolinium-based contrast agents in pediatric magnetic resonance imaging. Pediatr Radiol 47:507\u2013521","journal-title":"Pediatr Radiol"},{"key":"4154_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamapediatrics.2017.0264","volume":"171","author":"JS McDonald","year":"2017","unstructured":"McDonald JS, McDonald RJ, Jentoft ME et al (2017) Intracranial gadolinium deposition following gadodiamide-enhanced magnetic resonance imaging in pediatric patients: a case-control study. JAMA Pediatr 171:705\u2013707","journal-title":"JAMA Pediatr"},{"key":"4154_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2015142690","volume":"276","author":"T Kanda","year":"2015","unstructured":"Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228\u2013232","journal-title":"Radiology"},{"key":"4154_CR4","doi-asserted-by":"publisher","first-page":"e1637","DOI":"10.1542\/peds.2015-2222","volume":"136","author":"JH Miller","year":"2015","unstructured":"Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136:e1637\u2013e1640","journal-title":"Pediatrics"},{"key":"4154_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00247-017-3810-4","volume":"47","author":"LB Mithal","year":"2017","unstructured":"Mithal LB, Patel PS, Mithal D et al (2017) Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Pediatr Radiol 47:657\u2013664","journal-title":"Pediatr Radiol"},{"key":"4154_CR6","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3174\/ajnr.A4891","volume":"37","author":"DR Roberts","year":"2016","unstructured":"Roberts DR, Chatterjee AR, Yazdani M et al (2016) Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol 37:2340\u20132347","journal-title":"AJNR Am J Neuroradiol"},{"key":"4154_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","volume":"51","author":"N Murata","year":"2016","unstructured":"Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Investig Radiol 51:447\u2013453","journal-title":"Investig Radiol"},{"key":"4154_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/RLI.0000000000000266","volume":"51","author":"DR Roberts","year":"2016","unstructured":"Roberts DR, Lindhorst SM, Welsh CT et al (2016) High levels of gadolinium deposition in the skin of a patient with normal renal function. Investig Radiol 51:280\u2013289","journal-title":"Investig Radiol"},{"key":"4154_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2016152846","volume":"281","author":"N Maximova","year":"2016","unstructured":"Maximova N, Gregori M, Zennaro F et al (2016) Hepatic gadolinium deposition and reversibility after contrast agent-enhanced MR imaging of pediatric hematopoietic stem cell transplant recipients. Radiology 281:418\u2013426","journal-title":"Radiology"},{"key":"4154_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10534-016-9931-7","volume":"29","author":"M Rogosnitzky","year":"2016","unstructured":"Rogosnitzky M, Branch S (2016) Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals 29:365\u2013376","journal-title":"Biometals"},{"key":"4154_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2214\/AJR.15.15842","volume":"207","author":"RC Semelka","year":"2016","unstructured":"Semelka RC, Ramalho M, AlObaidy M, Ramalho J (2016) Gadolinium in humans: a family of disorders. AJR Am J Roentgenol 207:229\u2013233","journal-title":"AJR Am J Roentgenol"},{"key":"4154_CR12","unstructured":"U. S. Food and Drug Administration (2017) Drug safety communications. FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging. https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM455390.pdf . Accessed 17 April 2017"},{"key":"4154_CR13","unstructured":"European Medicines Agency (2017) PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2017\/03\/WC500223209.pdf . Accessed 17 April 2017"},{"key":"4154_CR14","unstructured":"American College of Radiology (2017) ACR manual on contrast media version 10.3 (78). https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Clinical-Resources\/Contrast_Media.pdf . Accessed 12 April 2018"},{"key":"4154_CR15","unstructured":"American College of Radiology (2017) News releases: ACR response to the European PRAC recommendations (April 4, 2017). http:\/\/www.publicnow.com\/view\/DA714236788989CE92F38E18EA3CCB6FCC9DFDE3?2017-04-04-17:31:30+01:00-xxx935 . Accessed 12 April 2018"},{"key":"4154_CR16","first-page":"205521731770445","volume":"3","author":"HK Goischke","year":"2017","unstructured":"Goischke HK (2017) Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues. Mult Scler J Exp Transl Clin 3:2055217317704450","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"4154_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3174\/ajnr.A5209","volume":"38","author":"A Gupta","year":"2017","unstructured":"Gupta A, Al-Dasuqi K, Xia F et al (2017) The use of noncontrast quantitative MRI to detect gadolinium-enhancing multiple sclerosis brain lesions: a systematic review and meta-analysis. AJNR Am J Neuroradiol 38:1317\u20131322","journal-title":"AJNR Am J Neuroradiol"},{"key":"4154_CR18","first-page":"633","volume-title":"Principles and practice of pediatric oncology.","author":"RL Heideman","year":"1993","unstructured":"Heideman RL (1993) Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott-Raven, Philadelphia, pp 633\u2013681"},{"key":"4154_CR19","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 17:iv1\u2013iv62","journal-title":"Neuro Oncol"},{"key":"4154_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/ern.09.4","volume":"9","author":"AC Albers","year":"2009","unstructured":"Albers AC, Gutmann DH (2009) Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother 9:535\u2013539","journal-title":"Expert Rev Neurother"},{"key":"4154_CR21","unstructured":"Recht LD (2017) Optic pathway glioma. In: UpToDate. https:\/\/www.uptodate.com\/contents\/optic-pathway-glioma . Accessed 12 April 2018"},{"key":"4154_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-016-2163-4","volume":"129","author":"MJ Wan","year":"2016","unstructured":"Wan MJ, Ullrich NJ, Manley PE et al (2016) Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. J Neuro Oncol 129:173\u2013178","journal-title":"J Neuro Oncol"},{"key":"4154_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00381-016-3262-4","volume":"33","author":"S Gaudino","year":"2017","unstructured":"Gaudino S, Martucci M, Russo R et al (2017) MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma. Childs Nerv Syst 33:35\u201354","journal-title":"Childs Nerv Syst"},{"key":"4154_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","volume":"100","author":"P Hernaiz Driever","year":"2010","unstructured":"Hernaiz Driever P, von Hornstein S, Pietsch T et al (2010) Natural history and management of low-grade glioma in NF-1 children. J Neuro Oncol 100:199\u2013207","journal-title":"J Neuro Oncol"},{"key":"4154_CR25","first-page":"1963","volume":"22","author":"L Kornreich","year":"2001","unstructured":"Kornreich L, Blaser S, Schwarz M et al (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 22:1963\u20131969","journal-title":"AJNR Am J Neuroradiol"},{"key":"4154_CR26","first-page":"1823","volume-title":"Walsh & Hoyt's clinical neuro-ophthalmology","author":"JB Kerrison","year":"2005","unstructured":"Kerrison JB (2005) Chapter 38: phacomatoses. In: Miller NR (ed) Walsh & Hoyt's clinical neuro-ophthalmology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1823\u20131898","edition":"6"},{"key":"4154_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1259\/bjr.74.877.740024","volume":"74","author":"JF Chateil","year":"2001","unstructured":"Chateil JF, Soussotte C, Pedespan JM et al (2001) MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis. Br J Radiol 74:24\u201331","journal-title":"Br J Radiol"},{"key":"4154_CR28","doi-asserted-by":"crossref","unstructured":"Prada CE, Hufnagel RB, Hummel TR et al (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 167:851\u2013856","DOI":"10.1016\/j.jpeds.2015.07.001"},{"key":"4154_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189\u2013198","journal-title":"Ann Neurol"},{"key":"4154_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","volume":"131","author":"LJ Balcer","year":"2001","unstructured":"Balcer LJ, Liu GT, Heller G et al (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas. Relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131:442\u2013445","journal-title":"Am J Ophthalmol"},{"key":"4154_CR31","first-page":"143","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Neuro Oncol 41:143\u2013149","journal-title":"Neuro Oncol"},{"key":"4154_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.icu.0000243016.90004.12","volume":"17","author":"GT Liu","year":"2006","unstructured":"Liu GT (2006) Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol 17:427\u2013431","journal-title":"Curr Opin Ophthalmol"},{"key":"4154_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","volume":"111","author":"S Thiagalingam","year":"2004","unstructured":"Thiagalingam S, Flaherty M, Billson F, North K (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568\u2013577","journal-title":"Ophthalmology"},{"key":"4154_CR34","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH et al (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology 14:790\u2013797","journal-title":"Neuro-Oncology"},{"key":"4154_CR35","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","volume":"30","author":"JL Ater","year":"2012","unstructured":"Ater JL, Zhou T, Holmes E et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's oncology group. J Clin Oncol 30:2641\u20132647","journal-title":"J Clin Oncol"},{"key":"4154_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ophtha.2011.12.035","volume":"119","author":"JP Kelly","year":"2012","unstructured":"Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231\u20131237","journal-title":"Ophthalmology"},{"key":"4154_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pbc.25480","volume":"62","author":"B Shofty","year":"2015","unstructured":"Shofty B, Mauda-Havakuk M, Weizman L et al (2015) The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer 62:1353\u20131359","journal-title":"Pediatr Blood Cancer"},{"key":"4154_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1470-2045(11)70057-2","volume":"12","author":"MJ Bent van den","year":"2011","unstructured":"van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583\u2013593","journal-title":"Lancet Oncol"},{"key":"4154_CR39","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","volume":"35","author":"PY Wen","year":"2017","unstructured":"Wen PY, Chang SM, Van den Bent MJ et al (2017) Response assessment in neuro-oncology clinical trials. J Clin Oncol 35:2439\u20132449","journal-title":"J Clin Oncol"},{"key":"4154_CR40","unstructured":"R Core Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. https:\/\/www.R-project.org . Accessed 14 March 2018"},{"key":"4154_CR41","unstructured":"Centers for Medicare and Medicaid Services (2017) Searchable Medicare physician fee schedule. http:\/\/www.cms.gov\/apps\/physician-fee-schedule\/overview.aspx . Accessed 12 Sept 2017"},{"key":"4154_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/689772","volume":"125","author":"J Clemens","year":"2017","unstructured":"Clemens J, Gottlieb JD (2017) In the shadow of a giant: Medicare's influence on private physician payments. J Polit Econ 125:1\u201339","journal-title":"J Polit Econ"},{"key":"4154_CR43","unstructured":"The Henry J. Kaiser Family Foundation (2016) State health facts \u2014 Medicaid-to-Medicare fee index (2016). http:\/\/www.kff.org\/state-category\/medicaid-chip\/medicaid-physician-fees\/ . Accessed 15 Sept 2017"},{"key":"4154_CR44","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","volume":"81","author":"T Taylor","year":"2008","unstructured":"Taylor T, Jaspan T, Milano G et al (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81:761\u2013766","journal-title":"Br J Radiol"},{"key":"4154_CR45","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2214\/AJR.07.2554","volume":"189","author":"JR Dillman","year":"2007","unstructured":"Dillman JR, Ellis JH, Cohan RH et al (2007) Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 189:1533\u20131538","journal-title":"AJR Am J Roentgenol"},{"key":"4154_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/02688690310001601216","volume":"17","author":"J Astrup","year":"2003","unstructured":"Astrup J (2003) Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17:327\u2013335","journal-title":"Br J Neurosurg"},{"key":"4154_CR47","doi-asserted-by":"crossref","unstructured":"Dodge HW Jr, Love JG, Craig WM et al (1958) Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79:607\u2013621","DOI":"10.1001\/archneurpsyc.1958.02340060003001"},{"key":"4154_CR48","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"4154_CR49","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3171\/jns.1993.78.6.0859","volume":"78","author":"IF Pollack","year":"1993","unstructured":"Pollack IF, Hoffman HJ, Humphreys RP, Becker L (1993) The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78:859\u2013863","journal-title":"J Neurosurg"},{"key":"4154_CR50","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/FOC-07\/11\/E1","volume":"23","author":"AG Lee","year":"2007","unstructured":"Lee AG (2007) Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 23:E1","journal-title":"Neurosurg Focus"},{"key":"4154_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00234-015-1612-7","volume":"58","author":"J Lambron","year":"2016","unstructured":"Lambron J, Rakotonjanahary J, Loisel D et al (2016) Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification. Neuroradiology 58:197\u2013208","journal-title":"Neuroradiology"},{"key":"4154_CR52","doi-asserted-by":"publisher","first-page":"052303","DOI":"10.1118\/1.4871040","volume":"41","author":"L Weizman","year":"2014","unstructured":"Weizman L, Sira LB, Joskowicz L et al (2014) Semiautomatic segmentation and follow-up of multicomponent low-grade tumors in longitudinal brain MRI studies. Med Phys 41:052303","journal-title":"Med Phys"},{"key":"4154_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.media.2011.07.001","volume":"16","author":"L Weizman","year":"2012","unstructured":"Weizman L, Ben Sira L, Joskowicz L et al (2012) Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI. Med Image Anal 16:177\u2013188","journal-title":"Med Image Anal"},{"key":"4154_CR54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00381-011-1436-7","volume":"27","author":"B Shofty","year":"2011","unstructured":"Shofty B, Weizman L, Joskowicz L et al (2011) MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm. Childs Nerv Syst 27:1265\u20131272","journal-title":"Childs Nerv Syst"},{"key":"4154_CR55","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00234-012-1010-3","volume":"54","author":"S Gaudino","year":"2012","unstructured":"Gaudino S, Quaglio F, Schiarelli C et al (2012) Spontaneous modifications of contrast enhancement in childhood non-cerebellar pilocytic astrocytomas. Neuroradiology 54:989\u2013995","journal-title":"Neuroradiology"},{"key":"4154_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000028944","volume":"32","author":"L Beni-Adani","year":"2000","unstructured":"Beni-Adani L, Gomori M, Spektor S, Constantini S (2000) Cyst wall enhancement in pilocytic astrocytoma: neoplastic or reactive phenomena. Pediatr Neurosurg 32:234\u2013239","journal-title":"Pediatr Neurosurg"},{"key":"4154_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02482173","volume":"21","author":"H Takeuchi","year":"2004","unstructured":"Takeuchi H, Kubota T, Sato K, Arishima H (2004) Ultrastructure of capillary endothelium in pilocytic astrocytomas. Brain Tumor Pathol 21:23\u201326","journal-title":"Brain Tumor Pathol"},{"key":"4154_CR58","doi-asserted-by":"crossref","unstructured":"Strong JA, Hatten HP Jr, Brown MT et al (1993) Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness. AJR Am J Roentgenol 161:369\u2013372","DOI":"10.2214\/ajr.161.2.8333380"},{"key":"4154_CR59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jon.12450","volume":"27","author":"N Jittapiromsak","year":"2017","unstructured":"Jittapiromsak N, Hou P, Liu HL et al (2017) Prognostic role of conventional and dynamic contrast-enhanced MRI in optic pathway gliomas. J Neuroimaging 27:594\u2013601","journal-title":"J Neuroimaging"},{"key":"4154_CR60","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00247-008-1003-x","volume":"38","author":"SC Jost","year":"2008","unstructured":"Jost SC, Ackerman JW, Garbow JR et al (2008) Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma. Pediatr Radiol 38:1293\u20131299","journal-title":"Pediatr Radiol"},{"key":"4154_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/adc.87.1.65","volume":"87","author":"S Singhal","year":"2002","unstructured":"Singhal S, Birch JM, Kerr B et al (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65\u201370","journal-title":"Arch Dis Child"},{"key":"4154_CR62","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.2016.71.7199","volume":"35","author":"J Campian","year":"2017","unstructured":"Campian J, Gutmann DH (2017) CNS tumors in neurofibromatosis. J Clin Oncol 35:2378\u20132385","journal-title":"J Clin Oncol"},{"key":"4154_CR63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/brain\/awg016","volume":"126","author":"JS Guillamo","year":"2003","unstructured":"Guillamo JS, Creange A, Kalifa C et al (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126:152\u2013160","journal-title":"Brain"},{"key":"4154_CR64","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00330-004-2433-y","volume":"15","author":"HJ Mentzel","year":"2005","unstructured":"Mentzel HJ, Seidel J, Fitzek C et al (2005) Pediatric brain MRI in neurofibromatosis type I. Eur Radiol 15:814\u2013822","journal-title":"Eur Radiol"},{"key":"4154_CR65","first-page":"541","volume":"19","author":"C Bonawitz","year":"1998","unstructured":"Bonawitz C, Castillo M, Chin CT et al (1998) Usefulness of contrast material in MR of patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 19:541\u2013546","journal-title":"AJNR Am J Neuroradiol"},{"key":"4154_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/RLI.0000000000000242","volume":"51","author":"G Jost","year":"2016","unstructured":"Jost G, Lenhard DC, Sieber MA et al (2016) Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents. Investig Radiol 51:83\u201389","journal-title":"Investig Radiol"},{"key":"4154_CR67","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/jmri.21971","volume":"30","author":"MA Sieber","year":"2009","unstructured":"Sieber MA, Steger-Hartmann T, Lengsfeld P, Pietsch H (2009) Gadolinium-based contrast agents and NSF: evidence from animal experience. J Magn Reson Imaging 30:1268\u20131276","journal-title":"J Magn Reson Imaging"},{"key":"4154_CR68","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1148\/radiol.2017162980","volume":"283","author":"A Radbruch","year":"2017","unstructured":"Radbruch A, Haase R, Kickingereder P et al (2017) Pediatric brain: no increased signal intensity in the dentate nucleus on unenhanced T1-weighted MR images after consecutive exposure to a macrocyclic gadolinium-based contrast agent. Radiology 283:828\u2013836","journal-title":"Radiology"},{"key":"4154_CR69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1148\/radiol.2016160356","volume":"282","author":"TF Flood","year":"2017","unstructured":"Flood TF, Stence NV, Maloney JA, Mirsky DM (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222\u2013228","journal-title":"Radiology"},{"key":"4154_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejrad.2008.01.026","volume":"66","author":"JL Abraham","year":"2008","unstructured":"Abraham JL, Thakral C (2008) Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Eur J Radiol 66:200\u2013207","journal-title":"Eur J Radiol"},{"key":"4154_CR71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/RMR.0000000000000109","volume":"25","author":"JR Costello","year":"2016","unstructured":"Costello JR, Kalb B, Martin DR (2016) Incidence and risk factors for gadolinium-based contrast agent immediate reactions. Top Magn Reson Imaging 25:257\u2013263","journal-title":"Top Magn Reson Imaging"},{"key":"4154_CR72","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1148\/radiol.12112025","volume":"264","author":"JW Jung","year":"2012","unstructured":"Jung JW, Kang HR, Kim MH et al (2012) Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 264:414\u2013422","journal-title":"Radiology"},{"key":"4154_CR73","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1056\/NEJMp1310583","volume":"369","author":"EC Stecker","year":"2013","unstructured":"Stecker EC, Schroeder SA (2013) Adding value to relative-value units. N Engl J Med 369:2176\u20132179","journal-title":"N Engl J Med"},{"key":"4154_CR74","unstructured":"The Henry J. Kaiser Family Foundation (2017) Next steps for CHIP: what is at stake for children? http:\/\/files.kff.org\/attachment\/Fact-Sheet-Next-Steps-for-CHIP-What-is-at-Stake-for-Children . Accessed 14 Sept 2017"},{"key":"4154_CR75","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00004424-198904000-00001","volume":"24","author":"DD Patton","year":"1989","unstructured":"Patton DD, Woolfenden JM (1989) A utility-based model for comparing the cost-effectiveness of diagnostic studies. Investig Radiol 24:263\u2013271","journal-title":"Investig Radiol"},{"key":"4154_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1148\/radiol.2441051790","volume":"244","author":"W Hollingworth","year":"2007","unstructured":"Hollingworth W, Jarvik JG (2007) Technology assessment in radiology: putting the evidence in evidence-based radiology. Radiology 244:31\u201338","journal-title":"Radiology"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-018-4154-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-018-4154-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-018-4154-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T04:54:53Z","timestamp":1571374493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-018-4154-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4154"],"URL":"https:\/\/doi.org\/10.1007\/s00247-018-4154-4","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}